The best-characterized "type" CBS 5926 strain is also deposited as ATCC 74012 and CNCM I-745. A CNCM I-1049 strain is also used; it is unclear whether it is the same as CBS 5926. Antibiotic-associated diarrhea Evidence exists for its use in the preventive treatment of antibiotic-associated diarrhea (AAD) in adults. Further evidence indicates its use to prevent AAD in children. The potential efficacy of probiotic AAD prevention is dependent on the probiotic strain(s) used and on the dosage. A 2015 meta-analysis of 21 randomised controlled trials (4780 participants) confirmed that<unk>  is effective in reducing the risk of AAD in children and adults. Lactobacillus rhamnosus or<unk>  at high doses (more than 5 billion colony-forming units/day) is moderately effective (with no serious side effects) for the prevention of AAD in children and might also reduce the duration of diarrhea. Clostridium difficile infection<unk>  showed reduction of relapses in some specific patients with recurrent Clostridium difficile infection and may be effective for secondary prevention of C. difficile infection. HIV/AIDS-associated diarrhea<unk>  has been shown to significantly increase the recovery rate of stage IV AIDS patients suffering from diarrhea versus placebo. On average, patients receiving<unk>  gained weight, while the placebo group lost weight over the 18-month trial. No adverse reactions were observed in these immunocompromised patients. Elimination of Helicobacter pylori infection The addition of<unk>  to the standard triple medication protocol for elimination of Helicobacter pylori infection showed a significant increase in eradication rates in a meta-analysis, though eradication rates were still not exceptional. The supplement also significantly decreased usual side effects of H. pylori eradication therapy including diarrhea and nausea. Blastocystosis Also, some evidence shows potential benefits of<unk>  in treatment of blastocystosis. Acute gastroenteritis A position paper published by ESPGHAN Working Group for Probiotics and Prebiotics based on a systematic reviews and randomized controlled trials suggested that<unk>  (low quality of evidence, strong recommendation) may be considered in the management of children with acute gastroenteritis in addition to rehydration therapy.
Saccharomyces boulardii
Candida tropicalis
Candida dubliniensis
Actinomyces naeslundii
Candida parapsilosis
Candida krusei
Aspergillus tubingensis
Talaromyces marneffei